http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008532723-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-4833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-363 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 |
| filingDate | 2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2008532723-A |
| titleOfInvention | Semisolid osteoblast composition for bone healing containing fibrin and method for producing the same |
| abstract | Disclosed is a semisolid osteoblast composition for fibrin-mixed fracture healing and a method for producing the same. Osteoblasts are separated from bone tissue and separated from DMEM (Dulbecco's M). modified Eagle's Medium) or α-MEM (Minimum) (Essential Medium, Alpha Modification) Suspension production step of producing an osteoblast suspension by growing and culturing in a culture solution, and mixing an clotting factor into the osteoblast suspension to provide an osteoblast therapeutic agent The composition consists of a therapeutic agent production stage to be produced. As a result, a mixture of osteoblasts and fibrin is injected into the site where the fracture should be healed for bone healing, so there is no clinical rejection and a uniform cell distribution, which is fixed to the affected area semisolid. The injection of the osteoblast composition allows for effective and rapid fracture healing. [Selection] Figure 3 |
| priorityDate | 2005-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.